Quantinuum Inc.
48.89USD
-1.5800 (-3.13%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.37▼ | $0 | 3 | 5 |
| Next quarter | $-0.39▼ | $0 | 4 | 4 |
| Current year | $-1.41▼ | $0 | 5 | 5 |
| Next year | $-1.6▼ | $0 | 3 | 5 |
Beat in 0 of the last 1
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.26 | $-0.28 | -0.02 (-8.2%) |
17 ratings from 13 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Rosenblatt | Maintained | Buy | $155 | Aug 19, 2026 |
| Bernstein | Maintained | Outperform | $94 $95 | Aug 12, 2026 |
| Rosenblatt | Maintained | Buy | $155 | Aug 12, 2026 |
| Needham | Reiterated | Buy | $100 | Aug 12, 2026 |
| Cantor Fitzgerald | Reiterated | Overweight | $90 | Aug 12, 2026 |
| Morgan Stanley | Initiated | Equal-Weight | $78 | Jun 29, 2026 |
| TD Cowen | Initiated | Buy | — | Jun 29, 2026 |
| UBS | Initiated | Buy | $93 | Jun 29, 2026 |
| JP Morgan | Initiated | Overweight | $97 | Jun 29, 2026 |
| Jefferies | Initiated | Buy | $90 | Jun 29, 2026 |
| Cantor Fitzgerald | Initiated | Overweight | $90 | Jun 29, 2026 |
| Craig-Hallum | Initiated | Buy | $100 | Jun 29, 2026 |
| Rosenblatt | Initiated | Buy | $155 | Jun 29, 2026 |
| Mizuho | Initiated | Outperform | $90 | Jun 29, 2026 |
| Evercore ISI Group | Initiated | Outperform | $98 | Jun 29, 2026 |
| B of A Securities | Initiated | Buy | $100 | Jun 29, 2026 |
| Needham | Initiated | Buy | $100 | Jun 29, 2026 |
22 filings from 13 insiders · 0 buy / 0 sell over 6m
Officers and directors of QNT, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SCHULMAN ROBIN J.Officer | Grant | 125.0k | — | — | Jul 17, 2026 |
| BHATIA MANISH HDirector | Buy | 20.0k | $60.00 | $1.20M | Jun 5, 2026 |
| KAPUR VIMAL MDirector | Buy | 13.0k | $60.00 | $780k | Jun 5, 2026 |
| SHARAN NITESHChief Financial Officer | Buy | 6.5k | $60.00 | $390k | Jun 5, 2026 |
| STEPNIAK MICHALDirector | Buy | 13.3k | $60.00 | $800k | Jun 5, 2026 |
| NARANG PRINEHADirector | Buy | 200 | $60.00 | $12k | Jun 5, 2026 |
| DAUGHERTY PAUL R.Director | Buy | 4.0k | $60.00 | $240k | Jun 5, 2026 |
| DEHOFF KEVIN SCOTTOfficer | Buy | 15.0k | $60.00 | $900k | Jun 5, 2026 |
| JIMENEZ JOSEPH JRDirector | Buy | 66.7k | $60.00 | $4.00M | Jun 5, 2026 |
| BARRON HAL VDirector | Buy | 250.0k | $60.00 | $15.00M | Jun 5, 2026 |
| DENMAN KENNETH DDirector | Buy | 14.0k | $60.00 | $840k | Jun 5, 2026 |
| BRANDERIZ ERICDirector | Buy | 8.3k | $60.00 | $500k | Jun 5, 2026 |
| SHARAN NITESHChief Financial Officer | Grant | 334.3k | — | — | Jun 4, 2026 |
| NARANG PRINEHADirector | Grant | 5.8k | — | — | Jun 4, 2026 |
| DAUGHERTY PAUL R.Director | Grant | 5.8k | — | — | Jun 4, 2026 |
| HAZRA RAJEEB PH.D.Chief Executive Officer | Grant | 1.12M | — | — | Jun 4, 2026 |
| JIMENEZ JOSEPH JRDirector | Grant | 5.8k | — | — | Jun 4, 2026 |
| BARRON HAL VDirector | Grant | 5.8k | — | — | Jun 4, 2026 |
| DENMAN KENNETH DDirector | Grant | 5.8k | — | — | Jun 4, 2026 |
| BRANDERIZ ERICDirector | Grant | 5.8k | — | — | Jun 4, 2026 |
No analyst notes on QNT yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 10 | 1 | 0 | 0 | Buy1.92 |
| 1 mo ago | 2 | 10 | 1 | 0 | 0 | Buy1.92 |